APR 04, 2018 10:05 AM PDT

Why is Whooping Cough Back?

WRITTEN BY: Kara Marker

Pertussis, or whooping cough, is back, and it’s at least partly because individuals who were vaccinated in the early days of the whooping cough vaccine - the 1930s, 40s, and 50s - are losing the protective effect awarded by the drug. Researchers from the University of Georgia are evaluating this trend and discussing what to do next.

Gram stain of the bacteria Bordetella pertussis. Credit: CDC Public Health Image Library

Whooping cough is a serious respiratory infection caused by the Bordetella pertussis bacteria. For babies and young children, whooping cough can be a dangerous affliction. Symptoms (cold-like, mild cough or fever) first begin within five or ten days of exposure to bacteria, but some babies with pertussis don’t cough at all. However, they do stop breathing and turn blue.

Vaccination for whooping cough began in the 1940s and directly resulted in a 100-fold decrease in reported cases of whooping cough. The vaccine was very effective at reducing the rate of disease even though not everyone at the time received the vaccine; a phenomenon called herd immunity protected those who chose not to get vaccinated or could not for medical or other reasons. Unfortunately, whooping cough has made a resurgence, a trend starting in the 1970s.

Interestingly, the rate of new whooping cough cases is increasing although the vaccine is given at an early age.

“There has been no change to the epidemiology of pertussis that is causing the rise in the number of cases," explained senior author Pejman Rohani. "Instead, it is a function of the way vaccines were administered over the decades. It is an effect that takes a long time to manifest."

The effect Rohani is talking about is the so-called “end of the honeymoon” period: the protective effects of the whooping cough vaccine given to now-elderly individuals when they were babies and young children is wearing off. Researchers first tested the possibility that the new generation of whooping cough vaccines are flawed, but there was no evidence to support that claim.

Instead, researchers found that protection against whooping cough can wear off as vaccinated individuals age. And as individuals who received vaccinations in the beginning days of whooping cough vaccination get older and the risk of their protection wearing off grows, there are more and more individuals at risk of whooping cough, mostly elderly people.

What can be done? Researchers advise to continue vaccinating schoolchildren, which the study identified as the “core transmission group” of whooping cough. This would provide protection for unprotected adults and senior citizens via herd immunity. And going forward, researchers want to investigate and evaluate the number and frequency of booster vaccines given for whooping cough protection.

The present study was published in the journal Science Translational Medicine.

Sources: Centers for Disease Control and Prevention, The Journal of Infectious Diseases, University of Georgia

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 09, 2020
Immunology
MAR 09, 2020
Mobilizing the brain's immune cells boosts memory
A study by researchers at Australia’s RMIT University has uncovered a surprising connection between immune cells i ...
APR 08, 2020
Drug Discovery & Development
APR 08, 2020
Does Tuberculosis Vaccine Really Defend from COVID-19?
The spread of COVID-19 has panned out very differently in different countries. While in some such as the US, the UK and ...
APR 14, 2020
Immunology
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 23, 2020
Immunology
APR 23, 2020
COVID "Immunity Passports" Are a No-Go
  Authorities are caught between dealing with the competing urgencies of abating the COVID-19 health crisis and the ...
APR 11, 2020
Drug Discovery & Development
APR 11, 2020
Promising Experimental Anti-Malarial Drug
At St. Jude Children’s Research Hospital, researchers discovered a fast-acting anti-malarial compound with promisi ...
MAY 21, 2020
Drug Discovery & Development
MAY 21, 2020
Molecular 'Switch' Makes Autoimmune Drugs Fight Cancer
Researchers from the Antibody and Vaccine Group at the University of Southampton, England, have identified a way to repu ...
Loading Comments...